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Perspective
Home Blood Pressure Monitoring: New Evidence for an
Expanded Role
Mark Caulfield*
Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
Cardiovascular disease is now the lead-
ing cause of death and disability worldwide
[1]. The application of electronic blood
pressure measurement (home or ambulato-
ry monitoring) has been shown to improve
the precision of diagnosis of hypertension
and is superior to conventional, or clinic,
blood pressure monitoring at predicting
prognosis in those with high blood pressure.
The global burden of hypertension now
affects over 1 billion people and contributes
to 80% of cardiovascular disease outcomes
in emergent economies [1]. From observa-
tional studies of blood pressure (mostly
clinic blood pressure) in 1 million people,
for every 20-mm Hg increment in systolic
blood pressure greater than 115 mm Hg,
there is an effective doubling of cardiovas-
cular mortality [2].
The Prognostic Role of
Electronic Blood Pressure
There are limited data on the use of
home blood pressure monitoring (HBPM)
to assess the cardiovascular risk of patients.
An analysis as part of the 2011 UK
National Institute for Health and Care
Excellence guideline for hypertension sug-
gested that ambulatory blood pressure
monitoring (ABPM) was superior to
HBPM and that both were superior to
clinic blood pressure monitoring (CBPM)
as a guide to adverse outcomes [3,4]. This
analysis led to the recommendation that
ABPM be used to confirm a diagnosis
when hypertension is suspected, but the
panel (in which I was a participant)
acknowledged that the relative lack of
data on HBPM might have affected
prognostic accuracy [3,4].
As published in this week’s PLOS
Medicine, Jan Staessen and colleagues
undertook an individual-patient meta-
analysis based on data from the Interna-
tional Database of Home Blood Pressure
in Relation to Cardiovascular Outcome.
The meta-analysis included 5,008 people
who had home and conventional blood
pressure measurements and were not being
treated with antihypertensive medications
that would have influenced prognostic
outcomes [5]. These measurements were
used to stratify participants into five
categories of blood pressure: optimal,
,120/,80 mm Hg; normal, 120–129/
80–84 mm Hg; high-normal, 130–139/
85–89 mm Hg; mild hypertension, 140–
159/90–99 mm Hg; and severe hyperten-
sion, $160/$100 mm Hg.
Home Blood Pressure
Monitoring Improves Risk
Stratification
In keeping with a previous analysis,
the meta-analysis found no significant
improvement in risk stratification in those
defined as severely hypertensive ($160/
$100 mm Hg); at these levels HBPM and
CBPM are both strong predictors of
outcomes. This is not unexpected; severe
hypertension does not lack precision in risk
stratification and is not difficult to decide
to treat. On the other hand, at every level
of blood pressure below severe hyperten-
sion, the additional measurements ob-
tained from HBPM improved risk stratifi-
cation, providing new evidence supporting
the use of HBPM in routine assessment of
risk. This result is important because it
could refine risk stratification in people
with optimal, normal, or high-normal
blood pressure based on CBPM, who are
not conventionally treated. In addition,
HBPM showed improved stratification of
risk in those with masked hypertension,
that is, those who have normal clinic blood
pressure but on HBPM or ABPM have
periods of elevated blood pressure and
may benefit from treatment [5].
These findings add depth to the evi-
dence base in favour of electronic blood
pressure monitoring in the form of HBPM.
However, the authors do not have data to
provide a head-to-head comparison of
HBPM and ABPM, which would be
valuable in assessing whether HBPM
could be of sufficient diagnostic and
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prognostic precision to replace ABPM in
the confirmation of a diagnosis informing
a decision to treat. In addition, they were
not able to standardise HBPM approach-
es, but that limitation would be more likely
to dilute the observed improved risk
stratification by HBPM than create a
spurious association. To address this issue
and validate these findings, the authors
suggest further comparative, prospective
randomised controlled trials would be
valuable [5].
The Potential Implications of
These Findings for Patients with
High Blood Pressure
As the authors suggest, the use of
electronic blood pressure monitoring
(HBPM and ABPM) is likely cost-effective,
allows more rapid diagnosis and treat-
ment, saves consultation time, and may in
some people avert treatment at least
temporarily [6]. In this study by Staessen
and colleagues, HBPM appears valuable
in assessing those at risk who would not
usually be considered as potentially bene-
fiting from treatment. With a growing
burden of high blood pressure and a
growing availability of affordable devices,
HBPM could be used to diagnose high
blood pressure and help decide whom to
treat. It empowers patients to take on a
role in assessment of their blood pressure.
Now, with smart phone applications that
accept automated data uploads from
HBPM and display blood pressure trends
over time, HBPM could help avoid travel
and may save time for the health care
team as they conduct remote consultations
exploiting electronic tools for communica-
tion.
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